Delavirdine

Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV-1 infection in combination with other antiretroviral agents. It binds directly to reverse transcriptase and blocks RNA-dependent and DNA-dependent DNA polymerase activities. Mediocon Inc supplies pharmaceutical-grade Delavirdine meeting IP, BP, EP, and USP standards.

Key Features

• Analgesic, antipyretic & anti-inflammatory
• USP/BP/IP compliant quality
• Widely used in cardiovascular therapy
• Suitable for tablet and effervescent formulations

Applications

• HIV-1 infection combination therapy
• HAART (Highly Active Antiretroviral Therapy)
• Antiretroviral drug formulations
• HIV clinical research applications

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings